Summary
- Current Price
- As of today, FENC price is $9.96, down -3.82% in the most recent trading session on
- Current Price All-Time High
- FENC price is currently -33.57% below its historical high of $14.99 set on
- Market Cap
- FENC current market cap is $349M, up +43.98% over the past 365 days
- Revenue
- FENC current annual revenue is $44.64M, down -6.09% year-over-year
- Next Earnings
- The next earnings release for FENC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fennec Pharmaceuticals Inc. |
| Ticker | NASDAQ: FENC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fennecpharma.com |
| Employees | 32 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $9.96 | ||
| Price, 1D Change | -3.82% | |
| $349M | ||
| - | ||
| - | ||
| 1.31 | ||
| $44.64M | ||
| Revenue, 1Y Change | -6.09% | |
| -$0.34 | ||
| EPS, 1Y Change | -2,030.63% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ADH | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.34 | ||
| EPS Estimate | $0.32 | N/A |
| EPS Est. Change | +194.46% | N/A |
| $44.64M | ||
| Revenue Estimate | $72.56M | N/A |
| Revenue Est. Change | +62.55% | N/A |
| $9.96 | ||
| Price Target | $18.00 | - |
| Price Tgt. Change | +80.81% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.09 | -$0.02 | +81.55% | |
| -$0.13 | -$0.34 | -158.26% | |
| $0.32 | N/A | +194.46% | |
| $0.95 | N/A | +378.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $56.05M | $47.54M | -15.19% | |
| $45.60M | $44.64M | -2.10% | |
| $72.56M | N/A | +62.55% | |
| $103.11M | N/A | +130.97% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +15.22% | ||
| +40.01% | ||
| +43.98% | ||
| +84.34% | ||
| -6.09% | ||
| +2,808.27% | ||
| -2,030.62% | ||
| +62.23% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $9.96 | ||
| $9.05 | ||
| $11.22 | ||
| $9.57 | ||
| $10.75 | ||
| -$0.23 | ||
| 1.31 | ||
| $0.52 | ||
| 44.69 | ||
| 45.94% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $44.64M | ||
| -$0.34 | ||
| $40.88M | ||
| 91.57% | ||
| -$6.74M | ||
| -14.07% | ||
| -$9.74M | ||
| -21.82% | ||
| -$6.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 6.34 | ||
| 6.19 | ||
| - | ||
| 4 | ||
| 2.68 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 5.89 | ||
| 8.23 | ||
| -200.42 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $35.12M | ||
| $36.79M | ||
| $70.58M | ||
| $66.69M | ||
| $35.11M | ||
| $10.52M | ||
| $0.00 | ||
| $0.00 | ||
| $4.64M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $54.74M | ||
| $47.62M | ||
| $3.76M | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $106.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$14.42M | ||
| $0.00 | ||
| $24.58M | ||
| $0.00 | ||
| -$14.42M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Piper Sandler | ||
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → |
Analyst sentiment
Institutional ownership
Screeners with FENC
FAQ
- What is the ticker symbol for Fennec Pharmaceuticals Inc.?
- The ticker symbol for Fennec Pharmaceuticals Inc. is NASDAQ:FENC
- Does Fennec Pharmaceuticals Inc. pay dividends?
- No, Fennec Pharmaceuticals Inc. does not pay dividends
- What sector is Fennec Pharmaceuticals Inc. in?
- Fennec Pharmaceuticals Inc. is in the Healthcare sector
- What industry is Fennec Pharmaceuticals Inc. in?
- Fennec Pharmaceuticals Inc. is in the Biotechnology industry
- What country is Fennec Pharmaceuticals Inc. based in?
- Fennec Pharmaceuticals Inc. is headquartered in United States
- When did Fennec Pharmaceuticals Inc. go public?
- Fennec Pharmaceuticals Inc. initial public offering (IPO) was on September 15, 2017
- Is Fennec Pharmaceuticals Inc. in the S&P 500?
- No, Fennec Pharmaceuticals Inc. is not included in the S&P 500 index
- Is Fennec Pharmaceuticals Inc. in the NASDAQ 100?
- No, Fennec Pharmaceuticals Inc. is not included in the NASDAQ 100 index
- Is Fennec Pharmaceuticals Inc. in the Dow Jones?
- No, Fennec Pharmaceuticals Inc. is not included in the Dow Jones index
- When was Fennec Pharmaceuticals Inc. last earnings report?
- Fennec Pharmaceuticals Inc.'s most recent earnings report was on August 11, 2026
- When does Fennec Pharmaceuticals Inc. report earnings?
- The next expected earnings date for Fennec Pharmaceuticals Inc. is November 12, 2026
Data Sources & References
- FENC Official Website fennecpharma.com
- FENC Profile on Yahoo Finance finance.yahoo.com/quote/FENC
- FENC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fenc